Immediate Impact
4 from Science/Nature 55 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Suicide and self-harm
2022 Standout
Works of Alan Green being referenced
CLOZAPINE VS. RISPERIDONE FOR PEOPLE WITH FIRST EPISODE SCHIZOPHRENIA AND CO-OCCURRING CANNABIS USE DISORDER
2010
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alan Green | 121 | 37 | 270 | 133 | 37 | 621 | |
| Danielle Charbonneau | 80 | 13 | 89 | 162 | 17 | 650 | |
| Lisa Lee | 39 | 18 | 87 | 152 | 33 | 615 | |
| Anja Kraus | 215 | 8 | 196 | 269 | 28 | 641 | |
| Richard Lucas | 11 | 16 | 115 | 329 | 39 | 603 | |
| Marco Tommasi | 39 | 14 | 110 | 281 | 67 | 693 | |
| Salvador Contreras | 19 | 4 | 263 | 87 | 42 | 681 | |
| Cheng Li | 154 | 28 | 85 | 72 | 38 | 667 | |
| Kerem Coşkun | 178 | 13 | 142 | 218 | 49 | 574 | |
| Simon Boag | 22 | 6 | 86 | 248 | 55 | 602 | |
| Tanya Tran | 53 | 3 | 162 | 238 | 29 | 731 |
All Works
Login with ORCID to disown or claim papers
Loading papers...